GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I’ve investigated whether this is the case. When investing, your capital is ...

European Commission approved GSK's Jemperli with chemotherapy for advanced or recurrent endometrial cancer, covering 75% of cases. RUBY trial showed Jemperli combo reduced death risk by 31% and ...

Goliath gets a nuclear weapon': Senate bill would keep Arizona voters from deciding zoning cases Honeywell's split brings new ... including pets Arizona says GlaxoSmithKline's greed endangered ...

Andy Biggs wants to abolish OSHA oversight nationwide Arizona says GlaxoSmithKline's greed endangered kids with asthma 500 active-duty soldiers from the 10th Mountain Division to deploy in Arizona ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Brand New Membership Level: Benzinga Trade Alerts GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from existing assets. At the JPMorgan Healthcare ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

reflecting a similar trajectory to GSK’s complete exit from Haleon in May 2024. These moves underline the companies’ attempts to redefine their post-split identities. Haleon’s strong market ...